Our People
The ACELYRIN Team
We are led by experienced biopharma executives with exceptional track records of building strong, innovative and diverse teams across the healthcare industry.
Shao-Lee Lin, MD, PhD
Founder and Chief Executive Officer
Gil Labrucherie
Chief Financial Officer
Melanie Gloria
Chief Operating Officer
Ken Lock
Chief Commercial Officer
Agnes Lee
Senior Vice President, Investor Relations and Corporate Communications
Shephard (Shep) Mpofu, MD, MRCP, FRCP
Senior Vice President, Development
Patricia Turney
Chief Technical Operations Officer
Ron Oyston
Chief People Officer
Mina Kim
Chief Legal and Administrative Officer
Latest Press Releases
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease
Press Release
ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept Data for Lonigutamab, First Subcutaneous Anti-IGF-1R to Demonstrate Clinical Responses in Thyroid Eye Disease
Read more 